Synergistic Enhancement of Efficacy of Platinum Drugs With Verteporfin in Ovarian Cancer Cells

BMC Cancer - United Kingdom
doi 10.1186/s12885-020-06752-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evaluation of the Efficacy of Paclitaxel With Curcumin Combination in Ovarian Cancer Cells

Oncology Letters
Cancer ResearchOncology
2016English

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

TCRP1 Expression Is Associated With Platinum Sensitivity in Human Lung and Ovarian Cancer Cells

Oncology Letters
Cancer ResearchOncology
2016English

Synergistic Cytotoxic Effect of Sulindac and Pyrrolidine Dithiocarbamate Against Ovarian Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2012English

Exosomes as Mediators of Platinum Resistance in Ovarian Cancer

Oncotarget
Oncology
2017English

Synergistic Induction of Apoptosis in Brain Cancer Cells by Targeted Codelivery of siRNA and Anticancer Drugs

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2011English

Synergistic Anti-Neoplastic Effect of AG1478 in Combination With Cisplatin or Paclitaxel on Human Endometrial and Ovarian Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2010English

Verteporfin, a Suppressor of YAP–TEAD Complex, Presents Promising Antitumor Properties on Ovarian Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Ovarian Cancer Animal Models for Preclinical Studies and Development of Ovarian Cancer Drugs

JURNAL ILMU KEFARMASIAN INDONESIA
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy